Sign In
Buy LLY
$1,185.71
-7.09 (-0.594%)
At Close: Aug 07, 2026
2 Unstoppable Growth Stocks to Buy in 2024
09:30am, Wednesday, 20'th Dec 2023
Eli Lilly's sales growth should accelerate next year now that Zepbound has obtained approval. PDD Holdings owns Temu, which is one of the most popular e-commerce sites in the world today.
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
07:00am, Wednesday, 20'th Dec 2023
Wall Street turned its focus to a handful of newer treatments in different disease areas in 2023, including weight loss medications and a new Alzheimer's drug.
5 Big Drug Stocks That May Continue to Outperform in 2024
10:31am, Monday, 18'th Dec 2023
Novo Nordisk (NVO), Eli Lilly (LLY), Vertex Pharmaceuticals (VRTX), Regeneron (REGN) and GSK (GSK) have been performing well this year. These stocks are poised to keep the momentum alive in 2024.
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
09:15am, Monday, 18'th Dec 2023
Understanding what's hot and what's not is key to investing in biopharma. Drugs like Ozempic are going to continue being very popular next year.
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
08:00am, Sunday, 17'th Dec 2023
2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance coverage and unpleasant side effects.
Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here's Why That Makes Eli Lilly Stock an Even Better Buy.
05:55am, Saturday, 16'th Dec 2023
A recent study found that patients who quit taking Lilly's Zepbound regain much of their weight. Investors viewed this as bad news for Lilly, but it's actually good news.
Wells Fargo's top pharma picks for 2024
05:33pm, Friday, 15'th Dec 2023
Mohit Bansal, Wells Fargo Analyst, joins 'Closing Bell: Overtime' to discuss Wells Fargo's pharma picks for 2024.
The New Magnificent 7: 7 Stocks Rising to Prominence
08:55am, Friday, 15'th Dec 2023
The magnificent seven stocks have had a fantastic 2023. Those firms dominate Silicon Valley and are amongst seven of the largest eight firms globally, as measured by market capitalization.
Where Will Eli Lilly Be in 5 Years?
06:15am, Friday, 15'th Dec 2023
Eli Lilly's recently approved weight-loss treatment Zepbound has the potential to be a game changer. The company has other weight-loss products in the works that could help it dominate the anti-obesit
What Are The Best Stocks To Invest In Now? 2 Health Care Stocks To Watch
11:29am, Wednesday, 13'th Dec 2023
Health care stocks to check out in the stock market now.
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:32am, Wednesday, 13'th Dec 2023
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Billionaire investor Ken Langone: Lilly will be the first trillion dollar drug company in history
10:08am, Wednesday, 13'th Dec 2023
Ken Langone, Invemed Associates chairman and Home Depot co-founder, joins 'Squawk Box' to discuss the state of the pharmaceutical industry, including Pfizer's weaker than expected 2024 forecast, the g
Strategist: Buy Baxter stock, skip Eli Lilly stock
04:18pm, Tuesday, 12'th Dec 2023
Novo Nordisk (NVO) was named Yahoo Finance's Company of the Year thanks to the success of its diabetes and weight loss drugs, Ozempic and Wegovy. But there are other ways you can play the GLP-1 hype.
LLY Down as Patients Regain Weight After Stopping Zepbound
03:02pm, Tuesday, 12'th Dec 2023
Full results from a late-stage study show that patients who stopped taking Eli Lilly's (LLY) weight-loss drug for over a year slowly started to regain their lost weight.
Eli Lilly Stock Slips After Reported Weight Gain In Users Who Quit Its Drug
04:45pm, Monday, 11'th Dec 2023
Eli Lilly (LLY) shares fell 2.3% Monday after a study conducted by the drug maker found patients who use its weight-loss treatments may gain weight once they stop taking the drugs.
